Working… Menu

RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00819546
Recruitment Status : Active, not recruiting
First Posted : January 9, 2009
Last Update Posted : November 27, 2018
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Brigham and Women's Hospital
Information provided by (Responsible Party):
Richard Stone, MD, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019